What is Steritec?
Steritec operates as a specialized contract provider, delivering high-precision ethylene oxide and steam sterilization services that are vital for the medical device and pharmaceutical sectors. Beyond core sterilization, the company maintains a comprehensive laboratory suite, offering critical testing services such as LAL endotoxin analysis, bioburden assessment, and EO residual monitoring. By integrating these technical capabilities with professional regulatory consulting, Steritec functions as a full-lifecycle partner for manufacturers navigating complex compliance landscapes. Their market position is defined by a commitment to quality assurance and the mitigation of contamination risks, ensuring that medical products meet stringent global safety standards before reaching clinical environments.
How much funding has Steritec raised?
Steritec has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Steritec
PPP
Public-Private Partnership
What's next for Steritec?
Following this late-stage capital infusion, Steritec is well-positioned to scale its infrastructure and enhance its laboratory service offerings. The strategic deployment of these funds will likely focus on expanding facility throughput to meet the rising demand for outsourced sterilization services, a sector currently experiencing significant tailwinds due to increased medical device production. Furthermore, the company is expected to leverage its consulting arm to deepen client relationships, providing end-to-end support that spans from initial product design to final regulatory approval. As the regulatory environment for medical device safety becomes increasingly rigorous, Steritec's ability to provide both technical execution and compliance expertise will be a primary driver of its long-term competitive advantage and sustained growth.
See full Steritec company page
